Document is current

Article History

Accepted: 24 February 2025

First Online: 5 March 2025

Declarations

:

: Patients have provided informed consent to use their clinical pictures.

: We confirm that the tables and figures are original.

: Financial interests: EÖ has received investigator grants from Amgen and Novartis (fees paid to the institution) and consultant and/or speaker honoraria from Sanofi-Genzyme and Pfizer (fees paid to the institution). OA has received investigator grant from Leo Pharma (fees paid to the institution), a consultant honorarium from L’Oréal/La Roche Posay, and speaker honoraria from L’Oréal/La Roche Posay, Bioderma/NAOS, Abbvie, and Sanofi-Genzyme. DP has received research fundings from Leo Foundation. Non-financial interests: EÖ is an unpaid member of Contact Dermatitis Editorial Advisory Board, the European Society of Contact Dermatitis (ESCD) Working Parties, and the European Academy of Dermatology and Venereology (EADV) Contact Dermatitis Task Force. OA is the Associate Editor of Contact Dermatitis (paid) and an unpaid chair, co-chair, or member of the ESCD Working Parties, as well as an unpaid member of the EADV Contact Dermatitis Task Force. DP is a Junior Editor of the Journal of the European Academy of Dermatology and Venereology (JEADV) (unpaid), and an unpaid member of the EADV Contact Dermatitis Task Force.

: All reported studies/experiments involving human or animal subjects performed by the authors were in accordance with the ethical standards of institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: EÖ has received investigator grants from Amgen and Novartis (fees paid to the institution) and consultant and/or speaker honoraria from Sanofi-Genzyme and Pfizer (fees paid to the institution). OA has received investigator grant from Leo Pharma (fees paid to the institution), a consultant honorarium from L’Oréal/La Roche Posay, and speaker honoraria from L’Oréal/La Roche Posay, Bioderma/NAOS, Abbvie, and Sanofi-Genzyme. DP has received research fundings from Leo Foundation.

: EÖ is an unpaid member of Contact Dermatitis Editorial Advisory Board, the European Society of Contact Dermatitis (ESCD) Working Parties, and the European Academy of Dermatology and Venereology (EADV) Contact Dermatitis Task Force. OA is the Associate Editor of Contact Dermatitis (paid) and an unpaid chair, co-chair, or member of the ESCD Working Parties, as well as an unpaid member of the EADV Contact Dermatitis Task Force. DP is a Junior Editor of the Journal of the European Academy of Dermatology and Venereology (JEADV) (unpaid), and an unpaid member of the EADV Contact Dermatitis Task Force.